Download presentation
Presentation is loading. Please wait.
Published byTine de Vries Modified over 5 years ago
1
The reversal of antagonists facilitates the peak rate of tension development
David A. Gabriel, PhD, Jeffrey R. Basford, MD, PhD, Kai-Nan An, PhD Archives of Physical Medicine and Rehabilitation Volume 82, Issue 3, Pages (March 2001) DOI: /apmr Copyright © 2001 American Congress of Rehabilitation Medicine and the American Academy of Physical Medicine and Rehabilitation Terms and Conditions
2
Fig. 1 A representative trial from a single subject. The rate of tension development (A), elbow extension moment (B), triceps brachii electromyographic activity (C), and biceps brachii electromyographic activity (D). Archives of Physical Medicine and Rehabilitation , DOI: ( /apmr ) Copyright © 2001 American Congress of Rehabilitation Medicine and the American Academy of Physical Medicine and Rehabilitation Terms and Conditions
3
Fig. 2 The means and SDs (vertical bars) for the peak rate of tension development (dF/dtmax) for the experimental and control groups. Archives of Physical Medicine and Rehabilitation , DOI: ( /apmr ) Copyright © 2001 American Congress of Rehabilitation Medicine and the American Academy of Physical Medicine and Rehabilitation Terms and Conditions
4
Fig. 3 The means and SDs (vertical bars) for triceps electromyographic mean spike (peak-to-peak) amplitude for the experimental and control groups. Archives of Physical Medicine and Rehabilitation , DOI: ( /apmr ) Copyright © 2001 American Congress of Rehabilitation Medicine and the American Academy of Physical Medicine and Rehabilitation Terms and Conditions
5
Fig. 4 The means and SDs (vertical bars) for triceps electromyographic mean spike frequency for the experimental and control groups. Archives of Physical Medicine and Rehabilitation , DOI: ( /apmr ) Copyright © 2001 American Congress of Rehabilitation Medicine and the American Academy of Physical Medicine and Rehabilitation Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.